0
     

Report Added
Report already added
Global Microbiome Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Microbiome Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

The Microbiome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microbiome Therapeutics size is estimated to be USD 191.6 million in 2026 from USD 62 million in 2020, with a change XX% between 2020 and 2021. The global Microbiome Therapeutics market size is expected to grow at a CAGR of 32.7% for the next five years.

Market segmentation
Microbiome Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Upper GIT
Lower GIT

Market segment by Application, can be divided into
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-Oncology
Others

Market segment by players, this report covers
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Microbiome Therapeutics
1.2 Classification of Microbiome Therapeutics by Type
1.2.1 Overview: Global Microbiome Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Microbiome Therapeutics Revenue Market Share by Type in 2020
1.2.3 Upper GIT
1.2.4 Lower GIT
1.3 Global Microbiome Therapeutics Market by Application
1.3.1 Overview: Global Microbiome Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-Oncology
1.3.5 Others
1.4 Global Microbiome Therapeutics Market Size & Forecast
1.5 Global Microbiome Therapeutics Market Size and Forecast by Region
1.5.1 Global Microbiome Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Microbiome Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Microbiome Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Microbiome Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Microbiome Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Microbiome Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Microbiome Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Microbiome Therapeutics Market Drivers
1.6.2 Microbiome Therapeutics Market Restraints
1.6.3 Microbiome Therapeutics Trends Analysis
2 Company Profiles
2.1 Seres Therapeutics
2.1.1 Seres Therapeutics Details
2.1.2 Seres Therapeutics Major Business
2.1.3 Seres Therapeutics Microbiome Therapeutics Product and Solutions
2.1.4 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Seres Therapeutics Recent Developments and Future Plans
2.2 Assembly Biosciences
2.2.1 Assembly Biosciences Details
2.2.2 Assembly Biosciences Major Business
2.2.3 Assembly Biosciences Microbiome Therapeutics Product and Solutions
2.2.4 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Assembly Biosciences Recent Developments and Future Plans
2.3 Synthetic Biologics
2.3.1 Synthetic Biologics Details
2.3.2 Synthetic Biologics Major Business
2.3.3 Synthetic Biologics Microbiome Therapeutics Product and Solutions
2.3.4 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Synthetic Biologics Recent Developments and Future Plans
2.4 Interxon
2.4.1 Interxon Details
2.4.2 Interxon Major Business
2.4.3 Interxon Microbiome Therapeutics Product and Solutions
2.4.4 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Interxon Recent Developments and Future Plans
2.5 PureTech
2.5.1 PureTech Details
2.5.2 PureTech Major Business
2.5.3 PureTech Microbiome Therapeutics Product and Solutions
2.5.4 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 PureTech Recent Developments and Future Plans
2.6 Synlogic
2.6.1 Synlogic Details
2.6.2 Synlogic Major Business
2.6.3 Synlogic Microbiome Therapeutics Product and Solutions
2.6.4 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Synlogic Recent Developments and Future Plans
2.7 Enterome BioScience
2.7.1 Enterome BioScience Details
2.7.2 Enterome BioScience Major Business
2.7.3 Enterome BioScience Microbiome Therapeutics Product and Solutions
2.7.4 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Enterome BioScience Recent Developments and Future Plans
2.8 4D Pharma
2.8.1 4D Pharma Details
2.8.2 4D Pharma Major Business
2.8.3 4D Pharma Microbiome Therapeutics Product and Solutions
2.8.4 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 4D Pharma Recent Developments and Future Plans
2.9 Second Genome
2.9.1 Second Genome Details
2.9.2 Second Genome Major Business
2.9.3 Second Genome Microbiome Therapeutics Product and Solutions
2.9.4 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Second Genome Recent Developments and Future Plans
2.10 AOBiome
2.10.1 AOBiome Details
2.10.2 AOBiome Major Business
2.10.3 AOBiome Microbiome Therapeutics Product and Solutions
2.10.4 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 AOBiome Recent Developments and Future Plans
2.11 C3 Jian
2.11.1 C3 Jian Details
2.11.2 C3 Jian Major Business
2.11.3 C3 Jian Microbiome Therapeutics Product and Solutions
2.11.4 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 C3 Jian Recent Developments and Future Plans
2.12 Rebiotix
2.12.1 Rebiotix Details
2.12.2 Rebiotix Major Business
2.12.3 Rebiotix Microbiome Therapeutics Product and Solutions
2.12.4 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Rebiotix Recent Developments and Future Plans
2.13 MicroBiome Therapeutics LLC
2.13.1 MicroBiome Therapeutics LLC Details
2.13.2 MicroBiome Therapeutics LLC Major Business
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions
2.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans
2.14 Metabiomics
2.14.1 Metabiomics Details
2.14.2 Metabiomics Major Business
2.14.3 Metabiomics Microbiome Therapeutics Product and Solutions
2.14.4 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Metabiomics Recent Developments and Future Plans
2.15 Ritter Pharmaceuticals
2.15.1 Ritter Pharmaceuticals Details
2.15.2 Ritter Pharmaceuticals Major Business
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions
2.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Ritter Pharmaceuticals Recent Developments and Future Plans
2.16 Symberix
2.16.1 Symberix Details
2.16.2 Symberix Major Business
2.16.3 Symberix Microbiome Therapeutics Product and Solutions
2.16.4 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Symberix Recent Developments and Future Plans
2.17 OpenBiome
2.17.1 OpenBiome Details
2.17.2 OpenBiome Major Business
2.17.3 OpenBiome Microbiome Therapeutics Product and Solutions
2.17.4 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 OpenBiome Recent Developments and Future Plans
2.18 Azitra
2.18.1 Azitra Details
2.18.2 Azitra Major Business
2.18.3 Azitra Microbiome Therapeutics Product and Solutions
2.18.4 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Azitra Recent Developments and Future Plans
2.19 Symbiotix Biotherapies
2.19.1 Symbiotix Biotherapies Details
2.19.2 Symbiotix Biotherapies Major Business
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions
2.19.4 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Symbiotix Biotherapies Recent Developments and Future Plans
2.20 Osel
2.20.1 Osel Details
2.20.2 Osel Major Business
2.20.3 Osel Microbiome Therapeutics Product and Solutions
2.20.4 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Osel Recent Developments and Future Plans
2.21 Metabogen
2.21.1 Metabogen Details
2.21.2 Metabogen Major Business
2.21.3 Metabogen Microbiome Therapeutics Product and Solutions
2.21.4 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Metabogen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Microbiome Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Microbiome Therapeutics Players Market Share
3.2.2 Top 10 Microbiome Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Microbiome Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Microbiome Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Microbiome Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Microbiome Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Microbiome Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Microbiome Therapeutics Revenue by Type (2016-2026)
6.2 North America Microbiome Therapeutics Revenue by Application (2016-2026)
6.3 North America Microbiome Therapeutics Market Size by Country
6.3.1 North America Microbiome Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Microbiome Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Microbiome Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Microbiome Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Microbiome Therapeutics Revenue by Type (2016-2026)
7.2 Europe Microbiome Therapeutics Revenue by Application (2016-2026)
7.3 Europe Microbiome Therapeutics Market Size by Country
7.3.1 Europe Microbiome Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Microbiome Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Microbiome Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Microbiome Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Microbiome Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Microbiome Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Microbiome Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Microbiome Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Microbiome Therapeutics Market Size by Region
8.3.1 Asia-Pacific Microbiome Therapeutics Revenue by Region (2016-2026)
8.3.2 China Microbiome Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Microbiome Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Microbiome Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Microbiome Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Microbiome Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Microbiome Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Microbiome Therapeutics Revenue by Type (2016-2026)
9.2 South America Microbiome Therapeutics Revenue by Application (2016-2026)
9.3 South America Microbiome Therapeutics Market Size by Country
9.3.1 South America Microbiome Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Microbiome Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Microbiome Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Microbiome Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Microbiome Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Microbiome Therapeutics Market Size by Country
10.3.1 Middle East & Africa Microbiome Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Microbiome Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Microbiome Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Microbiome Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Microbiome Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Microbiome Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Microbiome Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Microbiome Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Microbiome Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Seres Therapeutics Corporate Information, Head Office, and Major Competitors
Table 7. Seres Therapeutics Major Business
Table 8. Seres Therapeutics Microbiome Therapeutics Product and Solutions
Table 9. Seres Therapeutics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Assembly Biosciences Corporate Information, Head Office, and Major Competitors
Table 11. Assembly Biosciences Major Business
Table 12. Assembly Biosciences Microbiome Therapeutics Product and Solutions
Table 13. Assembly Biosciences Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Synthetic Biologics Corporate Information, Head Office, and Major Competitors
Table 15. Synthetic Biologics Major Business
Table 16. Synthetic Biologics Microbiome Therapeutics Product and Solutions
Table 17. Synthetic Biologics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Interxon Corporate Information, Head Office, and Major Competitors
Table 19. Interxon Major Business
Table 20. Interxon Microbiome Therapeutics Product and Solutions
Table 21. Interxon Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. PureTech Corporate Information, Head Office, and Major Competitors
Table 23. PureTech Major Business
Table 24. PureTech Microbiome Therapeutics Product and Solutions
Table 25. PureTech Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Synlogic Corporate Information, Head Office, and Major Competitors
Table 27. Synlogic Major Business
Table 28. Synlogic Microbiome Therapeutics Product and Solutions
Table 29. Synlogic Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Enterome BioScience Corporate Information, Head Office, and Major Competitors
Table 31. Enterome BioScience Major Business
Table 32. Enterome BioScience Microbiome Therapeutics Product and Solutions
Table 33. Enterome BioScience Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. 4D Pharma Corporate Information, Head Office, and Major Competitors
Table 35. 4D Pharma Major Business
Table 36. 4D Pharma Microbiome Therapeutics Product and Solutions
Table 37. 4D Pharma Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Second Genome Corporate Information, Head Office, and Major Competitors
Table 39. Second Genome Major Business
Table 40. Second Genome Microbiome Therapeutics Product and Solutions
Table 41. Second Genome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. AOBiome Corporate Information, Head Office, and Major Competitors
Table 43. AOBiome Major Business
Table 44. AOBiome Microbiome Therapeutics Product and Solutions
Table 45. AOBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. C3 Jian Corporate Information, Head Office, and Major Competitors
Table 47. C3 Jian Major Business
Table 48. C3 Jian Microbiome Therapeutics Product and Solutions
Table 49. C3 Jian Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Rebiotix Corporate Information, Head Office, and Major Competitors
Table 51. Rebiotix Major Business
Table 52. Rebiotix Microbiome Therapeutics Product and Solutions
Table 53. Rebiotix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. MicroBiome Therapeutics LLC Corporate Information, Head Office, and Major Competitors
Table 55. MicroBiome Therapeutics LLC Major Business
Table 56. MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions
Table 57. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Metabiomics Corporate Information, Head Office, and Major Competitors
Table 59. Metabiomics Major Business
Table 60. Metabiomics Microbiome Therapeutics Product and Solutions
Table 61. Metabiomics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Ritter Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 63. Ritter Pharmaceuticals Major Business
Table 64. Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions
Table 65. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Symberix Corporate Information, Head Office, and Major Competitors
Table 67. Symberix Major Business
Table 68. Symberix Microbiome Therapeutics Product and Solutions
Table 69. Symberix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. OpenBiome Corporate Information, Head Office, and Major Competitors
Table 71. OpenBiome Major Business
Table 72. OpenBiome Microbiome Therapeutics Product and Solutions
Table 73. OpenBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Azitra Corporate Information, Head Office, and Major Competitors
Table 75. Azitra Major Business
Table 76. Azitra Microbiome Therapeutics Product and Solutions
Table 77. Azitra Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Symbiotix Biotherapies Corporate Information, Head Office, and Major Competitors
Table 79. Symbiotix Biotherapies Major Business
Table 80. Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions
Table 81. Symbiotix Biotherapies Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Osel Corporate Information, Head Office, and Major Competitors
Table 83. Osel Major Business
Table 84. Osel Microbiome Therapeutics Product and Solutions
Table 85. Osel Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Metabogen Corporate Information, Head Office, and Major Competitors
Table 87. Metabogen Major Business
Table 88. Metabogen Microbiome Therapeutics Product and Solutions
Table 89. Metabogen Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Global Microbiome Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 91. Global Microbiome Therapeutics Revenue Share by Players (2019-2021)
Table 92. Breakdown of Microbiome Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Microbiome Therapeutics Players Head Office, Products and Services Provided
Table 94. Microbiome Therapeutics Mergers & Acquisitions in the Past Five Years
Table 95. Microbiome Therapeutics New Entrants and Expansion Plans
Table 96. Global Microbiome Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 97. Global Microbiome Therapeutics Revenue Share by Type (2016-2021)
Table 98. Global Microbiome Therapeutics Revenue Forecast by Type (2021-2026)
Table 99. Global Microbiome Therapeutics Revenue by Application (2016-2021)
Table 100. Global Microbiome Therapeutics Revenue Forecast by Application (2021-2026)
Table 101. North America Microbiome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 102. North America Microbiome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 103. North America Microbiome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 104. North America Microbiome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 105. North America Microbiome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 106. North America Microbiome Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 107. Europe Microbiome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 108. Europe Microbiome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 109. Europe Microbiome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 110. Europe Microbiome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 111. Europe Microbiome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 112. Europe Microbiome Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 113. Asia-Pacific Microbiome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 114. Asia-Pacific Microbiome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 115. Asia-Pacific Microbiome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 116. Asia-Pacific Microbiome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 117. Asia-Pacific Microbiome Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 118. Asia-Pacific Microbiome Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 119. South America Microbiome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 120. South America Microbiome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 121. South America Microbiome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 122. South America Microbiome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 123. South America Microbiome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 124. South America Microbiome Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Microbiome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 126. Middle East & Africa Microbiome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 127. Middle East & Africa Microbiome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 128. Middle East & Africa Microbiome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 129. Middle East & Africa Microbiome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 130. Middle East & Africa Microbiome Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures
Figure 1. Microbiome Therapeutics Picture
Figure 2. Global Microbiome Therapeutics Revenue Market Share by Type in 2020
Figure 3. Upper GIT
Figure 4. Lower GIT
Figure 5. Microbiome Therapeutics Revenue Market Share by Application in 2020
Figure 6. Inflammatory Bowel Disease (IBD) Picture
Figure 7. Orphan Drug Picture
Figure 8. Immuno-Oncology Picture
Figure 9. Others Picture
Figure 10. Global Microbiome Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Microbiome Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Microbiome Therapeutics Revenue Market Share by Region (2016-2026)
Figure 13. Global Microbiome Therapeutics Revenue Market Share by Region in 2020
Figure 14. North America Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Microbiome Therapeutics Market Drivers
Figure 20. Microbiome Therapeutics Market Restraints
Figure 21. Microbiome Therapeutics Market Trends
Figure 22. Seres Therapeutics Recent Developments and Future Plans
Figure 23. Assembly Biosciences Recent Developments and Future Plans
Figure 24. Synthetic Biologics Recent Developments and Future Plans
Figure 25. Interxon Recent Developments and Future Plans
Figure 26. PureTech Recent Developments and Future Plans
Figure 27. Synlogic Recent Developments and Future Plans
Figure 28. Enterome BioScience Recent Developments and Future Plans
Figure 29. 4D Pharma Recent Developments and Future Plans
Figure 30. Second Genome Recent Developments and Future Plans
Figure 31. AOBiome Recent Developments and Future Plans
Figure 32. C3 Jian Recent Developments and Future Plans
Figure 33. Rebiotix Recent Developments and Future Plans
Figure 34. MicroBiome Therapeutics LLC Recent Developments and Future Plans
Figure 35. Metabiomics Recent Developments and Future Plans
Figure 36. Ritter Pharmaceuticals Recent Developments and Future Plans
Figure 37. Symberix Recent Developments and Future Plans
Figure 38. OpenBiome Recent Developments and Future Plans
Figure 39. Azitra Recent Developments and Future Plans
Figure 40. Symbiotix Biotherapies Recent Developments and Future Plans
Figure 41. Osel Recent Developments and Future Plans
Figure 42. Metabogen Recent Developments and Future Plans
Figure 43. Global Microbiome Therapeutics Revenue Share by Players in 2020
Figure 44. Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Microbiome Therapeutics Revenue Market Share in 2020
Figure 46. Global Top 10 Players Microbiome Therapeutics Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Microbiome Therapeutics Revenue Share by Type in 2020
Figure 49. Global Microbiome Therapeutics Market Share Forecast by Type (2021-2026)
Figure 50. Global Microbiome Therapeutics Revenue Share by Application in 2020
Figure 51. Global Microbiome Therapeutics Market Share Forecast by Application (2021-2026)
Figure 52. North America Microbiome Therapeutics Sales Market Share by Type (2016-2026)
Figure 53. North America Microbiome Therapeutics Sales Market Share by Application (2016-2026)
Figure 54. North America Microbiome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 55. United States Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Microbiome Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. Europe Microbiome Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. Europe Microbiome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 61. Germany Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Microbiome Therapeutics Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Microbiome Therapeutics Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Microbiome Therapeutics Revenue Market Share by Region (2016-2026)
Figure 69. China Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Microbiome Therapeutics Sales Market Share by Type (2016-2026)
Figure 76. South America Microbiome Therapeutics Sales Market Share by Application (2016-2026)
Figure 77. South America Microbiome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Microbiome Therapeutics Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Microbiome Therapeutics Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Microbiome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Microbiome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source

Report Title: Global Microbiome Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2021-2025 Vietnam Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Vietnam Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Venezuela Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Venezuela Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Uruguay Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Uruguay Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 United Arab Emirates Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 United Arab Emirates Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Ukraine Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Ukraine Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Turkey Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Turkey Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers